ReviewFrontiers in immunology2022

The Therapeutic Potential for Targeting Group 2 Innate Lymphoid Cells in Asthma.

Takahiro Matsuyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.